US 12,110,283 B2 · Carbonic anhydrase targeting agents and methods of using same

Abstract

The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.

Claims1

Dependent claims

A carbonic anhydrase targeting agent represented by:

or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application

17/372,029Filed 9 Jul 2021 · continuation

Priority

9 May 2011

Published

US 2022/0023277 A127 Jan 2022

Granted

8 Oct 2024

Term ends

Not estimatedThe source records don’t support an estimate.

Classification30 codes

C07D 401/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms
A61K 31/433
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thidiazoles
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/444
Containing further heterocyclic ring systems: containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone

Family

Application61/483,979Us provisional application · filed 9 May 2011

Application13/467,694Parent of this division · filed 9 May 2012

Application16/286,901Parent of this continuation · filed 27 Feb 2019

US 10,221,159 B2Parent of this division · filed 5 Mar 2019

US 2022/0023277 A1Pre-grant publication · published 27 Jan 2022

US 11,059,802 B2Parent of this continuation

Application16/286,901Parent of this division

US 2012/0321563 A1Published application

US 2019/0300501 A1Published application

US 12,110,283 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

17/372,029Filed 9 Jul 2021 · continuation

Priority

9 May 2011

Published

US 2022/0023277 A127 Jan 2022

Granted

8 Oct 2024

Term ends

Not estimatedThe source records don’t support an estimate.

Classification30 codes

C07D 401/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms
A61K 31/433
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thidiazoles
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/444
Containing further heterocyclic ring systems: containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone

Family

Application61/483,979Us provisional application · filed 9 May 2011

Application13/467,694Parent of this division · filed 9 May 2012

Application16/286,901Parent of this continuation · filed 27 Feb 2019

US 10,221,159 B2Parent of this division · filed 5 Mar 2019

US 2022/0023277 A1Pre-grant publication · published 27 Jan 2022

US 11,059,802 B2Parent of this continuation

Application16/286,901Parent of this division

US 2012/0321563 A1Published application

US 2019/0300501 A1Published application

US 12,110,283 B2This patent

From the US filing history. Foreign family members aren’t listed.

Carbonic anhydrase targeting agents and methods of using same

Life of this patent

Abstract

Claims1

Carbonic anhydrase targeting agents and methods of using same

Life of this patent

Abstract

Claims1